Deca durabolin dangerous to the heart?

Anabolic androgenic steroids affect blood pressure, it can cause changes in the kidneys and in the heart (structural and functional changes). In addition, there are many doubts about the effect of SAA on the myocardium. Ana Paula Tanno et al 1 investigated the effect of administration of nandrolone to rats while training. 

The animals were given 5 mg of nandrolone per kg of body weight (twice a week) and they trained in a weight-bearing jump, and the weight was progressively increased (50%, 60% and 70% of body weight). Strength training and Nandrolone administration increased the hypertrophy left to the left ventricle and caused structural changes in the left ventricle Doping had an effect on the impairment of systolic and diastolic function.The researchers also marked the markers of pathological cardiac hypertrophy, which was linked to the administration of nandrolone to animals .. And how is it in humans? Baggish AL et al. 2 men published on May 23, 2017 took part in 140 men aged 34-54, experienced in strength training, in this group there were 86 taking SAA for more than 2 years and 54 men who did not reach for anabolic-androgenic steroids. transthoracic tomography and computed tomography angiography to assess the functioning of the heart. 


Summary, other experiments bring contradictory results regarding the effect of SAA on the potential hypertrophy, structure and function of the heart. 3-4 Persons using SAA should regularly examine the heart, at least performing an ECG and echo of the heart (ultrasound of the heart). The more so because hypertension and lipidogram disorders are classic symptoms in patients using SAA. The matter is complicated by the fact that the heart works are affected by beta mimetics (eg frequently abused clenbuterol, formoterol, salbutamol), dehydration (diuretics), use of growth hormone (and IGF-1) 6 and thyroid hormones. After all, bodybuilders are famous for this. 

Abuse of thyroid hormones can cause

ECG usually includes sinus tachycardia, shortened PR interval, extrasystolic arrhythmia or atrial fibrillation, QT interval shortening, ST segment elevation. 


You can read also: Synergy of supplements, part 6 – L-DOPA, 5-HTP and EGCG